Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing

PURPOSE: Erythropoietin (EPO) is a promising neuroprotective agent and is currently in Phase III clinical trials for the treatment of traumatic brain injury. The goal of this study was to determine if EPO is also protective in traumatic eye injury. METHODS: The left eyes of anesthetized DBA/2J or Ba...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Optom Vis Sci
Huvudupphovsmän: Bricker-Anthony, Courtney, D'Surney, Lauren, Lunn, Brendan, Hines-Beard, Jessica, Jo, Minhee, Bernardo-Colon, Alexandra, Rex, Tonia S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5206811/
https://ncbi.nlm.nih.gov/pubmed/27281679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/OPX.0000000000000898
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk